Avinger, Inc. (AVGR) |
3.93 -0.05 (-1.26%) 04-19 16:00 |
Open: | 3.9201 |
High: | 4.05 |
Low: | 3.9201 |
Volume: | 5,531 |
Market Cap: | 7(M) |
PE Ratio: | -0.17 |
Exchange: | NASDAQ Capital Market |
Industry: | Medical - Instruments & Supplies |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 5.10 |
Resistance 1: | 4.37 |
Pivot price: | 3.65 |
Support 1: | 3.40 |
Support 2: | 2.80 |
52w High: | 18 |
52w Low: | 2.5 |
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
EPS | -23.310 |
Book Value | -4.850 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | -239.42 |
Operating Margin (%) | -242.13 |
Return on Assets (ttm) | -54.8 |
Return on Equity (ttm) | 0.0 |
Wed, 03 Apr 2024
Avinger (AVGR) Announces 2.05M Share Offering by Selling Stockholders - StreetInsider.com
Thu, 21 Mar 2024
Avinger, Inc. (NASDAQ:AVGR) Q4 2023 Earnings Call Transcript - Yahoo Finance
Wed, 20 Mar 2024
Avinger: Q4 Earnings Snapshot - Houston Chronicle
Wed, 20 Mar 2024
AVGR Stock Earnings: Avinger Misses Revenue for Q4 2023 - InvestorPlace
Wed, 20 Mar 2024
Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript - Seeking Alpha
Thu, 07 Mar 2024
Avinger Expands Market Reach and Secures $15M Funding - TipRanks.com - TipRanks
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |